Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

KIAA1683 Inhibitors

KIAA1683, also known as Astrotactin 2 (ASTN2), is a protein that plays a crucial role in neuronal migration and the architectural structuring of the brain. This protein functions by mediating the adhesion between migrating neurons and the glial fibers along which they move, a process fundamental to the proper layering and organization of neurons in the developing brain. ASTN2's activity is vital for the formation of structured neural networks, which are essential for effective neural function and connectivity. In addition to its roles in development, ASTN2 may also be involved in synaptic plasticity and the maintenance of neural circuits in adulthood, suggesting its importance in both brain development and its ongoing function.

The inhibition of KIAA1683/ASTN2 can disrupt normal brain development and function, potentially leading to neurological deficits or disorders. Inhibition could occur through various biological mechanisms, including genetic mutations that result in the loss of function or reduced expression of the ASTN2 gene. Such genetic variations can diminish the production or functional capability of the ASTN2 protein, thereby impairing neuron migration and proper brain layering. Additionally, post-translational modifications such as phosphorylation or ubiquitination might alter the protein's stability, localization, or interaction with other proteins, further inhibiting its function in neuron adhesion and migration. Environmental factors, such as toxins or nutritional deficiencies, could also play a role in inhibiting ASTN2 function indirectly by affecting the cellular environment and the molecular pathways that regulate protein expression and activity. Understanding these inhibition mechanisms is essential for elucidating the pathophysiological basis of related neurological conditions and could be crucial for developing intervention strategies that address these developmental anomalies.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Fenofibrate

49562-28-9sc-204751
5 g
$41.00
9
(1)

A PPARα agonist affecting lipid metabolism, which can influence KIAA1683 if involved in lipid-related cellular activities.

Carfilzomib

868540-17-4sc-396755
5 mg
$41.00
(0)

A proteasome inhibitor which can affect protein degradation, offering insight into KIAA1683’s role in this area.

VX 809

936727-05-8sc-474670
10 mg
$592.00
(0)

A CFTR corrector affecting chloride channel regulation, potentially affecting KIAA1683's involvement in ion homeostasis.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Targets RAF kinases and VEGFRs, influencing cell proliferation and angiogenesis, thereby affecting KIAA1683 if involved in these pathways.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

A DNA methyltransferase inhibitor affecting gene expression, potentially modifying KIAA1683’s regulatory functions.

Mebendazole

31431-39-7sc-204798
sc-204798A
5 g
25 g
$46.00
$89.00
2
(2)

Impacts microtubule function and might offer insights into KIAA1683's role in cellular architecture.

Simvastatin

79902-63-9sc-200829
sc-200829A
sc-200829B
sc-200829C
50 mg
250 mg
1 g
5 g
$31.00
$89.00
$135.00
$443.00
13
(1)

An HMG-CoA reductase inhibitor affecting cholesterol biosynthesis, possibly affecting KIAA1683 if it plays a role in lipid homeostasis.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

Targets EGFR and inhibits tyrosine kinase activity, affecting KIAA1683 if it operates within these signaling routes.

Tyrphostin B42

133550-30-8sc-3556
5 mg
$26.00
4
(1)

Inhibits JAK2, potentially affecting STAT signaling pathways, and consequently the functions KIAA1683 may be involved in.